Calabrese Salvatore 4
4 · Gain Therapeutics, Inc. · Filed Jul 19, 2022
Insider Transaction Report
Form 4
Calabrese Salvatore
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-07-15+59,400→ 59,400 totalExercise: $4.01Exp: 2032-07-15→ Common Stock (59,400 underlying) - Award
Restricted Stock Units
2022-07-15+9,900→ 9,900 total→ Common Stock (9,900 underlying)
Footnotes (3)
- [F1]The shares underlying the option shall vest 25% on July 1, 2023 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
- [F3]The RSUs shall vest 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.